Ultrasensitive detection of ovarian cancer biomarker using Au nanoplate SERS immunoassay

Cited 2 time in scopus
Metadata Downloads
Title
Ultrasensitive detection of ovarian cancer biomarker using Au nanoplate SERS immunoassay
Author(s)
Gayoung Eom; Ahreum Hwang; Hongki Kim; Jeong Moon; Hyunju Kang; Juyeon JungEun Kyung LimJinyoung Jeong; H G Park; Taejoon Kang
Bibliographic Citation
Biochip Journal, vol. 15, pp. 348-355
Publication Year
2021
Abstract
Ovarian cancer is the ffth leading cause of cancer-related deaths among women. In particular, it is a high cause of mortality among women in industrialized countries. Human epididymis protein 4 (HE4) has recently emerged as a serological biomarker for the diagnosis of ovarian cancer. Herein, we report the ultrasensitive detection of HE4 using a gold (Au) nanoplate (NPl)-based surface-enhanced Raman scattering (SERS) immunoassay, wherein a capture antibody-immobilized Au NPl acts as an immune substrate and detection antibody-immobilized Au nanoparticles (NPs) serve as immunoprobes. The presence of the target biomarker (HE4) results in the formation of a sandwich structure of Au NPls and NPs, providing strong SERS signals. The developed method allows us to detect HE4 at low concentrations of 10 -17 M. The selective detection of HE4 was verifed using the Au NPl SERS immunoassay. We anticipate that the current approach could be helpful for the early diagnosis of ovarian cancer and eventually applied for diverse biomarker detection.
Keyword
Human epididymis protein 4ImmunoassayNanoparticleNanoplateOvarian cancerSurface-enhanced Raman scattering
ISSN
1976-0280
Publisher
Springer
DOI
http://dx.doi.org/10.1007/s13206-021-00031-2
Type
Article
Appears in Collections:
Division of Biomaterials Research > Bionanotechnology Research Center > 1. Journal Articles
Division of Research on National Challenges > Environmental diseases research center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.